ENHANCING ONCOLOGY ANALYSIS WITH INTEGRATED KRAS ASSAY COMPANIES AND RAS ASSAYS

within the promptly evolving subject of oncology exploration, accurate and successful mutation screening is very important for developing specific therapies. The KRAS Services System plays a pivotal purpose in this landscape by offering thorough options for KRAS mutation profiling and Examination. KRAS mutations, present in approximately 95% of RAS